Page last updated: 2024-11-02

pindolol and Glomerulonephritis

pindolol has been researched along with Glomerulonephritis in 1 studies

Pindolol: A moderately lipophilic beta blocker (ADRENERGIC BETA-ANTAGONISTS). It is non-cardioselective and has intrinsic sympathomimetic actions, but little membrane-stabilizing activity. (From Martindale, The Extra Pharmocopoeia, 30th ed, p638)
pindolol : A member of the class of indols which is the 2-hydroxy-3-(isopropylamino)propyl ether derivative of 1H-indol-4-ol.

Glomerulonephritis: Inflammation of the renal glomeruli (KIDNEY GLOMERULUS) that can be classified by the type of glomerular injuries including antibody deposition, complement activation, cellular proliferation, and glomerulosclerosis. These structural and functional abnormalities usually lead to HEMATURIA; PROTEINURIA; HYPERTENSION; and RENAL INSUFFICIENCY.

Research Excerpts

ExcerptRelevanceReference
" The daily dosage of mepindolol was 5 mg for patients with glomerular filtration rates 30% and higher and 2."1.27The 24-hour control of blood pressure in hypertension of chronic renal disease with mepindolol. ( García Rohles, R; Parada, J; Rodríguez Alvariño, J; Ruilope, L, 1983)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Parada, J1
Ruilope, L1
García Rohles, R1
Rodríguez Alvariño, J1

Other Studies

1 other study available for pindolol and Glomerulonephritis

ArticleYear
The 24-hour control of blood pressure in hypertension of chronic renal disease with mepindolol.
    Clinical therapeutics, 1983, Volume: 5, Issue:5

    Topics: Adult; Chronic Disease; Dose-Response Relationship, Drug; Female; Glomerulonephritis; Humans; Hypert

1983